These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 23095848)

  • 1. Reducing available soluble β-amyloid prevents progression of cerebral amyloid angiopathy in transgenic mice.
    Gregory JL; Prada CM; Fine SJ; Garcia-Alloza M; Betensky RA; Arbel-Ornath M; Greenberg SM; Bacskai BJ; Frosch MP
    J Neuropathol Exp Neurol; 2012 Nov; 71(11):1009-17. PubMed ID: 23095848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human apolipoprotein E4 alters the amyloid-beta 40:42 ratio and promotes the formation of cerebral amyloid angiopathy in an amyloid precursor protein transgenic model.
    Fryer JD; Simmons K; Parsadanian M; Bales KR; Paul SM; Sullivan PM; Holtzman DM
    J Neurosci; 2005 Mar; 25(11):2803-10. PubMed ID: 15772340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kinetics of cerebral amyloid angiopathy progression in a transgenic mouse model of Alzheimer disease.
    Robbins EM; Betensky RA; Domnitz SB; Purcell SM; Garcia-Alloza M; Greenberg C; Rebeck GW; Hyman BT; Greenberg SM; Frosch MP; Bacskai BJ
    J Neurosci; 2006 Jan; 26(2):365-71. PubMed ID: 16407531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ApoA-I deficiency increases cortical amyloid deposition, cerebral amyloid angiopathy, cortical and hippocampal astrogliosis, and amyloid-associated astrocyte reactivity in APP/PS1 mice.
    Button EB; Boyce GK; Wilkinson A; Stukas S; Hayat A; Fan J; Wadsworth BJ; Robert J; Martens KM; Wellington CL
    Alzheimers Res Ther; 2019 May; 11(1):44. PubMed ID: 31084613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cerebral amyloid angiopathy: an overview.
    Yamada M
    Neuropathology; 2000 Mar; 20(1):8-22. PubMed ID: 10935432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early Aβ reduction prevents progression of cerebral amyloid angiopathy.
    Schelle J; Wegenast-Braun BM; Fritschi SK; Kaeser SA; Jährling N; Eicke D; Skodras A; Beschorner N; Obermueller U; Häsler LM; Wolfer DP; Mueggler T; Shimshek DR; Neumann U; Dodt HU; Staufenbiel M; Jucker M
    Ann Neurol; 2019 Oct; 86(4):561-571. PubMed ID: 31359452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebrovascular dysfunction in amyloid precursor protein transgenic mice: contribution of soluble and insoluble amyloid-beta peptide, partial restoration via gamma-secretase inhibition.
    Han BH; Zhou ML; Abousaleh F; Brendza RP; Dietrich HH; Koenigsknecht-Talboo J; Cirrito JR; Milner E; Holtzman DM; Zipfel GJ
    J Neurosci; 2008 Dec; 28(50):13542-50. PubMed ID: 19074028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibody-mediated clearance of amyloid-beta peptide from cerebral amyloid angiopathy revealed by quantitative in vivo imaging.
    Prada CM; Garcia-Alloza M; Betensky RA; Zhang-Nunes SX; Greenberg SM; Bacskai BJ; Frosch MP
    J Neurosci; 2007 Feb; 27(8):1973-80. PubMed ID: 17314293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cerebral amyloid angiopathy and dementia.
    Tian J; Shi J; Mann DM
    Panminerva Med; 2004 Dec; 46(4):253-64. PubMed ID: 15876981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Border-associated macrophages promote cerebral amyloid angiopathy and cognitive impairment through vascular oxidative stress.
    Uekawa K; Hattori Y; Ahn SJ; Seo J; Casey N; Anfray A; Zhou P; Luo W; Anrather J; Park L; Iadecola C
    Mol Neurodegener; 2023 Oct; 18(1):73. PubMed ID: 37789345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Murine versus human apolipoprotein E4: differential facilitation of and co-localization in cerebral amyloid angiopathy and amyloid plaques in APP transgenic mouse models.
    Liao F; Zhang TJ; Jiang H; Lefton KB; Robinson GO; Vassar R; Sullivan PM; Holtzman DM
    Acta Neuropathol Commun; 2015 Nov; 3():70. PubMed ID: 26556230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Review: sporadic cerebral amyloid angiopathy.
    Attems J; Jellinger K; Thal DR; Van Nostrand W
    Neuropathol Appl Neurobiol; 2011 Feb; 37(1):75-93. PubMed ID: 20946241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amyloid-β contributes to blood-brain barrier leakage in transgenic human amyloid precursor protein mice and in humans with cerebral amyloid angiopathy.
    Hartz AM; Bauer B; Soldner EL; Wolf A; Boy S; Backhaus R; Mihaljevic I; Bogdahn U; Klünemann HH; Schuierer G; Schlachetzki F
    Stroke; 2012 Feb; 43(2):514-23. PubMed ID: 22116809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fruquintinib/HMPL-013 ameliorates cognitive impairments and pathology in a mouse model of cerebral amyloid angiopathy (CAA).
    Zhou G; Xiang T; Xu Y; He B; Wu L; Zhu G; Xie J; Yao L; Xiao Z
    Eur J Pharmacol; 2023 Jan; 939():175446. PubMed ID: 36470443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resorufin analogs preferentially bind cerebrovascular amyloid: potential use as imaging ligands for cerebral amyloid angiopathy.
    Han BH; Zhou ML; Vellimana AK; Milner E; Kim DH; Greenberg JK; Chu W; Mach RH; Zipfel GJ
    Mol Neurodegener; 2011 Dec; 6():86. PubMed ID: 22192811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Noninvasive magnetic resonance imaging detection of cerebral amyloid angiopathy-related microvascular alterations using superparamagnetic iron oxide particles in APP transgenic mouse models of Alzheimer's disease: application to passive Abeta immunotherapy.
    Beckmann N; Gérard C; Abramowski D; Cannet C; Staufenbiel M
    J Neurosci; 2011 Jan; 31(3):1023-31. PubMed ID: 21248127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of clusterin shifts amyloid deposition to the cerebrovasculature via disruption of perivascular drainage pathways.
    Wojtas AM; Kang SS; Olley BM; Gatherer M; Shinohara M; Lozano PA; Liu CC; Kurti A; Baker KE; Dickson DW; Yue M; Petrucelli L; Bu G; Carare RO; Fryer JD
    Proc Natl Acad Sci U S A; 2017 Aug; 114(33):E6962-E6971. PubMed ID: 28701379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Passive immunotherapy targeting amyloid-β reduces cerebral amyloid angiopathy and improves vascular reactivity.
    Bales KR; O'Neill SM; Pozdnyakov N; Pan F; Caouette D; Pi Y; Wood KM; Volfson D; Cirrito JR; Han BH; Johnson AW; Zipfel GJ; Samad TA
    Brain; 2016 Feb; 139(Pt 2):563-77. PubMed ID: 26493635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progression of cerebral amyloid angiopathy in transgenic mouse models of Alzheimer disease.
    Domnitz SB; Robbins EM; Hoang AW; Garcia-Alloza M; Hyman BT; Rebeck GW; Greenberg SM; Bacskai BJ; Frosch MP
    J Neuropathol Exp Neurol; 2005 Jul; 64(7):588-94. PubMed ID: 16042310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of Cerebral Amyloid Angiopathy in Two Transgenic Mouse Models of Cerebral β-Amyloidosis: A Neuropathological Study.
    Marazuela P; Paez-Montserrat B; Bonaterra-Pastra A; Solé M; Hernández-Guillamon M
    Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.